How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like Fresenius Medical Care To Acquire NxStage To Strengthen Its Vertically Integrated Dialysis Business August 6, 2017 Women in Biotech Underrepresented on Boards of Directors Across the Bay Area February 22, 2018 QuintilesIMS Reports Fourth-Quarter And Full-Year 2016 Results, Issues First-Quarter And Full-Year 2017 Guidance February 13, 2017
Fresenius Medical Care To Acquire NxStage To Strengthen Its Vertically Integrated Dialysis Business August 6, 2017
QuintilesIMS Reports Fourth-Quarter And Full-Year 2016 Results, Issues First-Quarter And Full-Year 2017 Guidance February 13, 2017
